Steris | STE - Spese Di Vendita E Di Amministrazione

Prezzo Delle Azioni
221.80
Cambio Giornaliero
-1.72 -0.77%
Mensile
-0.71%
Annuale
-1.42%
Q2 Previsione
220.82




Spese Di Vendita E Di Amministrazione Cambiamento Data
3M USD 744M 221M 2026-03
Accuray USD 127.32M 500.16M 2025-09
Avanos Medical USD 78.8M 1.2M 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
CONMED USD 166.76M 26.42M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Ecolab USD 1.06B 18.2M 2025-12
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Fortive USD 417.4M 10.2M 2025-12
Getinge SEK 2.65B 452M 2024-12
Globus Medical USD 318.48M 4.88M 2025-12
Haemonetics USD 109.15M 7.54M 2025-12
Idexx Laboratories USD 275.68M 10.58M 2025-12
Inogen USD 43.77M 510K 2024-06
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
Intuitive Surgical USD 613.3M 73.8M 2026-03
J&J USD 6.03B 719M 2026-03
Masimo USD 128M 11.6M 2025-12
Olympus JPY 125.65B 5.75B 2025-12
Orthofix International USD 130.35M 11.31M 2025-12
Owens Minor USD 258.98M 7.5M 2025-12
ResMed USD 278.4M 19.2M 2025-12
Steris USD 352.3M 2.6M 2025-12
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12